8-K/A

AMENDMENT NO. 1 FOR FORM 8-K

Company: Alaunos Therapeutics, Inc.
Filed: June 8, 2015
Period of Report: March 27, 2015
Accession Number: 0001193125-15-216013

View Document ↗ View on SEC.gov ↗